Hosted on MSN1mon
Pfizer going 'all in' on obesity drug development, CEO Bourla saysPfizer is testing multiple doses of once-a-day version of its weight-loss pill, after scrapping development of a twice-daily version of the drug in late 2023. "At this point, I'm very cautious ...
Bourla plans to donate his prize money to “projects aimed at preserving the memory of the victims of the Holocaust, with a particular emphasis on the tragedy suffered by the Greek Jewish ...
Kennedy Jr. In a Tuesday earnings call, CEO Albert Bourla said Trump had introduced him to Kennedy, a longtime vaccine critic, and the duo ended up having dinner together. Bourla did not specify ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results